Top Markets
#1 Cross Cross +15.68%
#2 Gama Token Gama Token +8.43%
#3 Glidr Glidr +5.05%
#4 Humanity Humanity +5.03%
#5 TDCCP TDCCP +4.85%
#6 龙虾 (Lobster) 龙虾 (Lobster) +4.82%
#7 Akedo Akedo +4.60%
#8 LEO Token LEO Token +4.58%
#9 Pieverse Pieverse +4.12%
#10 Berachain Berachain +3.39%
Coin of the day
Cross Cross
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Guard Therapeutics International AB (publ) Guard Therapeutics International AB (publ)

Guard Therapeutics International AB (publ)

GUARD
Kedudukan dalam Saham #36113
Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company... Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the diagnosis and management of acute kidney injuries. A key offering is ROSGard, a biological drug candidate designed to prevent kidney impairment through the protection, purification, and restoration of affected cells and tissues. Founded in 2008, the company operated as A1M Pharma AB (publ) until its renaming to Guard Therapeutics International AB (publ) in October 2019. Its headquarters are located in Stockholm, Sweden.
Harga Saham
$0.14966934
Disegerakkan terakhir: 2026-08-14
Modal Pasaran
$3.02M
Perubahan (1 hari)
3.72%
Perubahan (1 tahun)
-93.70%
Negara
SE
Perdagangan Guard Therapeutics International AB (publ) (GUARD)

Kategori

Healthcare
Pendapatan untuk Guard Therapeutics International AB (publ) (GUARD)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Guard Therapeutics International AB (publ), pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Guard Therapeutics International AB (publ) dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE